Laurence J, Friedman S M, Chartash E K, Crow M K, Posnett D N
Laboratory for Acquired Immunodeficiency Syndrome (AIDS) Virus Research, Hospital for Special Surgery, New York.
J Clin Invest. 1989 Jun;83(6):1843-8. doi: 10.1172/JCI114090.
HIV selectively inhibited the proliferative response of clonal CD4+ T lymphocytes to alloantigen while other alloantigen-dependent responses were unperturbed. Specifically, impaired blastogenesis could be dissociated from alloantigen-specific induction of the B cell activation molecule CD23, IL-4 release, and inositol lipid hydrolysis. In addition, membrane expression of pertinent T cell receptor molecules, including CD2, CD3, and T cell antigen receptor (Ti), remained intact. Using two MHC class II-specific human CD4+ helper T cell clones, the proliferative defect was shown to be an early consequence of HIV infection, occurring within 4 d of viral inoculation and preceding increases in mature virion production. It was generalizable to three distinct methods of T cell activation, all independent of antigen-presenting cells: anti-CD3 mediated cross-linking of the CD3/Ti complex; anti-CD2 and phorbol 12-myristic 13-acetate (PMA); and anti-CD28 plus PMA. These abnormalities were not mitigated by addition of exogenous IL-2, even though expression of the IL-2 receptor (CD25) was unaltered. These studies define a selective blockade in T cell function early after HIV exposure that could serve as a model for certain in vivo manifestations of AIDS.
人类免疫缺陷病毒(HIV)选择性地抑制克隆性CD4 + T淋巴细胞对同种异体抗原的增殖反应,而其他依赖同种异体抗原的反应则不受影响。具体而言,增殖能力受损与B细胞活化分子CD23的同种异体抗原特异性诱导、白细胞介素-4(IL-4)释放及肌醇脂质水解无关。此外,相关T细胞受体分子的膜表达,包括CD2、CD3和T细胞抗原受体(Ti),保持完整。利用两个II类主要组织相容性复合体(MHC)特异性人类CD4 +辅助性T细胞克隆,发现增殖缺陷是HIV感染的早期后果,发生在病毒接种后4天内,且早于成熟病毒体产量的增加。这一现象可推广至三种不同的T细胞激活方法,所有这些方法均独立于抗原呈递细胞:抗CD3介导的CD3/Ti复合体交联;抗CD2与佛波醇12 -肉豆蔻酸酯13 -乙酸酯(PMA);以及抗CD28加PMA。即使白细胞介素-2受体(CD25)的表达未改变,添加外源性IL-2也不能减轻这些异常。这些研究明确了HIV暴露后早期T细胞功能的选择性阻断,这可作为艾滋病某些体内表现的模型。